TerminatedPhase 3ketamine
Intravenous Subdissociative-dose Ketamine Versus Morphine for Prehospital Analgesia
Sponsored by Nantes University Hospital
NCT ID
NCT03236805
Target Enrollment
285 participants
Start Date
2017-11-23
Est. Completion
2022-11-26
About This Study
This is a prospective, randomized, single-blind trial evaluating prehospital patients experiencing moderate to severe acute pain, defined as a numeric rating scale score greater than or equal to 5. Patients will be randomized to receive ketamine at or morphine by intravenous push.
Conditions Studied
Interventions
- •Ketamine
- •Morphine
Eligibility
Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria: * older than 18 years old * prehospital moderate to severe acute pain, defined as a numeric rating scale score greater than or equal to 5 Exclusion Criteria: * unstable vital signs (systolic blood pressure \<90 or \>200 mm Hg, pulse rate \<50 or \>150 beats/min, and respiration rate \<10 or \>30 breaths/min) * pregnancy * breast-feeding * altered mental status * unable to give numeric rating scale scores * allergy to morphine or ketamine * acute pulmonary edema * acute coronary syndrome * renal or hepatic insufficiency * patient who received morphine for the same acute pain * acute psychiatric illness
Study Locations (12)
Angers University Hospital
Angers, France
University Hospital of Bordeaux
Bordeaux, France
Hospital of Chateaubriant
Châteaubriant, France
CH de Gonesse
Gonesse, France
Grenoble University Hospital
Grenoble, France
La Roche sur Yon Hospital
La Roche-sur-Yon, France
Le Mans University Hospital
Le Mans, France
Nantes University Hospital
Nantes, France
Quimper Hospital
Quimper, France
Rennes University Hospital
Rennes, France
+2 more locations